Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
作者： Man-Fung Yuen , Erwin Sablon , Chee-Kin Hui , He-Jun Yuan , Hilde Decraemer
关键词: Alanine transaminase 、 Orthohepadnavirus 、 Nucleoside analogue 、 Hepatitis B 、 Medicine 、 Hepatitis B virus 、 HBeAg 、 Hepadnaviridae 、 Lamivudine 、 Virology
摘要: … John Chi-Hang Yuen, Mr. Ringo Chi-Hang Wu, and Mr. Charles Tze-Kin Cheng, Department … Lai CL, Yuen MF. Profound suppression of of hepatitis B virus replication with lamivudine. J …
core.ac.uk
hku.hk
alkamallab.com 参考文章(25)
David A. Hendricks, Barbara J. Stowe, Bradley S. Hoo, Janice Kolberg, Bruce D. Irvine, Paul D. Neuwald, Mickey S. Urdea, Robert P. Perrillo, Quantitation of HBV DNA in Human Serum Using a Branched DNA (bDNA) Signal Amplification Assay American Journal of Clinical Pathology. ,vol. 104, pp. 537- 546 ,(1995) , 10.1093/AJCP/104.5.537
SN Si Ahmed, D Tavan, C Pichoud, F Berby, L Stuyver, M Johnson, P Merle, H Abidi, C Trépo, F Zoulim, Early Detection of Viral Resistance by Determination of Hepatitis B Virus Polymerase Mutations in Patients Treated by Lamivudine for Chronic Hepatitis B Hepatology. ,vol. 32, pp. 1078- 1088 ,(2000) , 10.1053/JHEP.2000.19619
R Ling, T J Harrison, Functional analysis of mutations conferring lamivudine resistance on hepatitis B virus. Journal of General Virology. ,vol. 80, pp. 601- 606 ,(1999) , 10.1099/0022-1317-80-3-601
Rong-Nan Chien, Yun-Fan Liaw, Mark Atkins, None, Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Hepatology. ,vol. 30, pp. 770- 774 ,(1999) , 10.1002/HEP.510300313
Marchelle I. Allen, Manon Deslauriers, C. Webster Andrews, Graham A. Tipples, Kathie-Anne Walters, David L. Tyrrell, Nathaniel Brown, Lynn D. Condreay, , Identification and characterization of mutations in hepatitis B virus resistant to lamivudine Hepatology. ,vol. 27, pp. 1670- 1677 ,(1998) , 10.1002/HEP.510270628
Chau-Ting Yeh, Rong-Nan Chien, Chia-Ming Chu, Yun-Fan Liaw, Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology. ,vol. 31, pp. 1318- 1326 ,(2000) , 10.1053/JHEP.2000.7296
Yun-Fan Liaw, Rong-Nan Chien, Chau-Ting Yeh, Sun-Lung Tsai, Chia-Ming Chu, Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy Hepatology. ,vol. 30, pp. 567- 572 ,(1999) , 10.1002/HEP.510300221
Suzane Kioko Ono-Nita, Naoya Kato, Yasushi Shiratori, Tsutomu Masaki, Keng-Hsin Lan, Flair Jos� Carrilho, Masao Omata, YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection. Hepatology. ,vol. 29, pp. 939- 945 ,(1999) , 10.1002/HEP.510290340
Hans L. Tillmann, Christian Trautwein, Thomas Bock, Klaus H. Böker, Elmar Jäckel, Medea Glowienka, Karl Oldhafer, Insa Bruns, Josee Gauthier, Lynn D. Condreay, Hans-Rudolf Raab, Michael P. Manns, Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Hepatology. ,vol. 30, pp. 244- 256 ,(1999) , 10.1002/HEP.510300141
Yun–Fan Liaw, Nancy WY Leung, Ting–Tsung Chang, Richard Guan, Dar–In Tai, Keng–Yeen Ng, Rong–Nan Chien, Julie Dent, Lise Roman, Sally Edmundson, Ching–Lung Lai, Asia Hepatitis Lamivudine Study Group, None, Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology. ,vol. 119, pp. 172- 180 ,(2000) , 10.1053/GAST.2000.8559